Send to

Choose Destination
Transplantation. 1988 Aug;46(2 Suppl):128S-134S.

Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants.

Author information

Immunology Department, Institute of Animal Physiology and Genetics Research, Babraham, Cambridge.


Treatment of normal rats with certain monoclonal anti-CD4 antibodies, beginning on the day of grafting, prevents heart graft rejection across a full MHC-haplotype mismatch. Adequate doses of antibody MRC OX-35, which is very potent in vivo, led to the induction of authentic specific tolerance of the transplants. In the very stringent grafting test of transplantation of DA skin to high-responder LOU recipients, adjunctive therapy with cyclosporine, in addition to the anti-CD4 antibodies, is required to induce tolerance. Since tolerance persists indefinitely after a 30-day course of treatment and appears to involve T cell-mediated suppression, this form of treatment is of potential clinical interest.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center